Transforming Lonza Specialty Ingredients into a Modern Chemicals Business

Transcription

1 Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business Increasing Market Focus Towards the Healthcare Continuum Sven Abend, COO Specialty Ingredients Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October 2016

2 Additional Information and Disclaimer Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited ( SGX- ST ). Lonza Group Ltd is not subject to the SGX-ST s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual. Certain matters discussed in this presentation may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this presentation due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this presentation. Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

3 Strategic Focus in Specialty Ingredients: From Fringe to Core in the Healthcare Continuum Water Treatment Hygiene / Preservation Personal Care Nutritional Supplements Agro Ingredients Coatings and Composites Healthcare Continuum Medicine Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

4 # of Lonza technology platforms Leveraging Our Anti-Microbial Expertise Building on the Most Comprehensive Portfolio in the Market Operating in 15 highly regulated antimicrobial fields of application in 4 target markets Providing 25 technology platforms from single ingredient to turnkey solution, fully serviced with application technology and regulatory support # of Regulated Anti-Microbial Applications Consumer Care Agro Ingredients Coatings&Composites Water Treatment Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

5 # of Lonza Technology Platforms Understanding Market Leadership Responsibility to Innovate for Sustainable Added Value Most-trusted industry partner in regulated anti-microbial applications around the globe Most-innovative solution provider in an ever-changing market environment Most-motivated industry participant, continuously investing into new platforms to address unmet customer needs # of Regulated Anti-Microbial Applications No.1 in institutional disinfection anti-fouling No.1 in 22 anti-dandruff No.1 in Consumer Care Agro Ingredients Coatings&Composites Water Treatment Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

6 Extending Lonza s Biotech Footprint into Consumer Product Ingredients Lonza pioneered biotechnology-derived skin care actives 5-fold increase in biotech-based personal care product launches over last 10 years Mammalian Cells Stem cell technology likely to become the next wave in skin care with Lonza at the innovation forefront Microalgae Plant Cells Microbial Ferments Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

7 Specialty Ingredients Value-Adding Growth at the Core of the Healthcare Continuum Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

8 Hand Hygiene Turnkey Solutions for Anti-Bacterial Applications A sustainable growing global market need in a complex regulatory environment We strategically invest to support the growth of this category Lonza s regulatory activities and competency proactively shape the market environment and make us the preferred partner Targeting to become the No. 1 provider of Consumer and Institutional Hand Hygiene Solutions Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

9 Preventive Health Care and Well Being Through Consumer Relevant Personal Care Technology Ensuring consumer safety in topical applications, through modern cutting-edge preservation systems Expanding our leading anti-dandruff position Exploring the blend of Lonza s biopharma and specialty ingredients expertise to enrich our innovation pipeline Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

10 Science-Based Nutraceutical Ingredients Addressing Growing Consumer Needs in Changing Demographics Strategic portfolio diversification into the most-attractive supplement markets Sports Nutrition Weight Management Adult Nutrition Health Prevention Lonza InterHealth Lonza / InterHealth Muscle Health Energy Muscle Health Joint Health Cognitive Health Immune Health Diabetic Heart Health Pet Health Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

11 Active Portfolio Management From Value Creation to Sustainable Growth Momentum Creating Momentum Modern New Offerings Innovating through application- and bio-technology with modern business models Step-Change Growth Turnkey Solutions Creating value through integrated solutions in highly regulated markets Accelerated Growth Specialty Ingredients Extending positions in quality-driven markets and growth regions GDP Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October

12 Summary The Healthcare Continuum spans from Pharma across Specialty Ingredients markets. Lonza s focus here intensifies. Regulatory environments across the Healthcare Continuum are complex. Regulated product services intrinsically bond Lonza Specialty Ingredients target markets. Lonza Specialty Ingredients is transforming. Portfolio reinvigoration with fewer standard ingredients means increasing bottom line with top-line growth to follow. Capital Markets Day Transforming Lonza Specialty Ingredients into a Modern Chemicals Business, Sven Abend, 27 October